FORGOT YOUR DETAILS?

Belrina Suspension

75

Description

What is Belrina?

Beauty of Belrina lies in the combination of medicinal herbs with definite anti-diarrheoal and antidysenteric effects accompanied with antispasmodic, antiflatulent, astringent, antiemetic and digestive properties.  Aegle marmelos (being the principal ingredient) alongwith Amomum aromaticum, Glycyrrhiza glabra, Polygonum aviculare, Althaea officinalis & Lawsonia inermis.

Where Belrina works?

Diarrhoea & dysentery, Adjuvant therapy for amoebiasis & giardiasis with accompanied disorders like flatulence, colic, nausea and loss of appetite.

How does Belrina work?

Aegle marmelos has its historic and established scientific use in chronic diarrhea and dysentery without any side effects. It has strong adsorbent and absorbent as well as anti bacterial properties. All other ingredients synergize the effects of main antidiarheoal and antidysenteric agent and act as helping factors due to their astringent, anti bacterial, antispasmodic, carminative and antiemetic role.

What are unwanted effects of Belrina?

No side effects & adverse reactions are reported within therapeutic dose.

What amount to be taken?

 

Up to 6 months:                                   2.5ml

6-12 months:                                          5 ml

1-5 years:                                        5-10 ml

5-12 years:                                    10-15 ml

Above 12 years:                               20 ml

 

3-4 times daily or as prescribed by the physician.

Treatment should be continued at least for one week to minimize the chances of recurrence of disease.

 

What are possible precautions?

 

Patients hypersensitive to any of the Belrina suspension ingredients should avoid it.

How supplied?

Suspension: 60 ml bottle with measuring spoon.

 

Always natural in Origin
Brick Laboratories (Unani)

Lahore-Pakistan.
AN ISO 9001 : 2000 CERTIFIED COMPANY

Reviews

There are no reviews yet.

Be the first to review “Belrina Suspension”

Your email address will not be published. Required fields are marked *

TOP